Literature DB >> 16143136

Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice.

Hiroko Saito Akei1, Anil Mishra, Carine Blanchard, Marc E Rothenberg.   

Abstract

BACKGROUND & AIMS: Eosinophilic esophagitis (EE) is frequently associated with atopic disease, including dermatitis and asthma. Data are emerging that atopic skin may provide an early entry point for antigen sensitization. We aimed to test the hypothesis that epicutaneous exposure to antigen primes for subsequent respiratory antigen-induced EE.
METHODS: Wild-type and genetically engineered mice were subjected to epicutaneous antigen sensitization and the development of experimental EE, and immune responses were examined.
RESULTS: We show that exposure to antigen via the epicutaneous route primes for marked eosinophilic inflammation in the esophagus triggered by a single airway antigen challenge. The development of experimental EE is associated with significant skin eosinophilia, accelerated bone marrow eosinophilopoiesis, blood eosinophilia, and large increases in serum antigen-specific immunoglobulin G1/immunoglobulin E using ovalbumin or Aspergillus fumigatus as the epicutaneous antigen. Mechanistic analysis with gene-targeted mice showed that interleukin-5 was required for esophageal eosinophilia and that interleukin-4, interleukin-13, and STAT6 contributed to a lesser extent.
CONCLUSIONS: These findings provide the first evidence that epicutaneous exposure to allergens potently primes for EE via a Th2-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143136     DOI: 10.1053/j.gastro.2005.06.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  75 in total

Review 1.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

Review 2.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 3.  Role of genetics, environment, and their interactions in the pathogenesis of eosinophilic esophagitis.

Authors:  John Lyles; Marc Rothenberg
Journal:  Curr Opin Immunol       Date:  2019-05-25       Impact factor: 7.486

Review 4.  Allergic eosinophilic esophagitis.

Authors:  Kevin C Bax; Sandeep K Gupta
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

Review 5.  The Role of the Environment in Eosinophilic Esophagitis.

Authors:  Paul J Dowling; Hannah Neuhaus; Brooke I Polk
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

Review 6.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

7.  Linking impaired skin barrier function to esophageal allergic inflammation via IL-33.

Authors:  Jared Travers; Mark Rochman; Cora E Miracle; Jared P Cohen; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2016-09-21       Impact factor: 10.793

8.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

Review 9.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

Review 10.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.